2283: Oncimmune Reports Substantial Growth in their Interim Results & Alan Green on 3 Companies
The SharePickers Podcast with Justin Waite - Un pódcast de Justin Waite
Categorías:
Oncimmune reports substantial revenue growth achieved with increased commercial activity across the business and Alan Green discusses Synairgen, Destiny Pharma and Mode Global Holdings
